HempFusion Wellness Submits Novel Foods Dossier to your great britain’s Regulatory Food …

DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a health that is leading health CBD business utilising the energy of whole-food hemp nourishment, is happy to announce it has submitted its dossier to your great britain’s Regulatory Food protection Agency (the “FSA”).

HempFusion, along with its strategic and supply that is exclusive partner, has submitted its novel foods application to the FSA with the coordination of a leading regulatory agency in Europe. This submission represents the step that is first the United Kingdom’s (the “UK”) regulatory approval procedure necessary to enable products which contain CBD become in love with the racks of stores in britain. The distribution includes an in depth analysis for the quality, security and security of HempFusion’s natural components and lots of product that is unique. The submission also includes compliant labeling and testing requirements and complete toxicology data in addition to proprietary heirloom hemp-sourcing and state-of-the-art low pressure and low-temperature C02 extraction methods.

The business’s give attention to conformity and sourcing premium materials that are raw substantiates the quality of HempFusion’s exclusive Organic Panoramic Hemp Extract and strategically positions HempFusion for continued sales within one of the largest markets in Europe, the UK. HempFusion believes the submission is an step that is essential finding your way through expected European Union (the “EU”) laws.

“We think great britain’s choice to permit CBD businesses to acquire a Novel Food Authorization through the FSA is a step that is tremendous for the global CBD industry,” commented Jason Mitchell, N.D., HempFusion’s Co-Founder and Chief Executive Officer. “HempFusion was built on the pillars of regulatory compliance. We have invested time that is significant resources, and power to make sure our services and products meet with the greatest requirements, so we are happy to report our distribution includes finished toxicology information, which might express probably one of the most complete submissions up to now. We anticipate dealing with the FSA as laws continue steadily to evolve in the British. This distribution securely establishes HempFusion as a leader that is future great britain market,” proceeded Dr. Mitchell.

The food that is novel’s primary function is to assess CBD product safety, including detailed toxicology studies. HempFusion places significant importance on safety for its consumers as evidenced by its participation and co-sponsoring of many studies and clinical trials, such as the Company’s participation in ValidCare’s liver and reproductive toxicity study, believed to be the CBD that is largest peoples observational research up to now.

The organization has entered European countries through Ireland and appears ahead to keeping its long history of conformity by fulfilling certain requirements for the FSA in front of its broader prepared expansion through the British plus the EU to further establish it as a leader that is global.


HempFusion is a health that is leading wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and safety that is human HempFusion’s diverse product profile comprises 48 SKUs including tinctures, proprietary Food And Drug Administration Drug indexed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and much more. With a focus that is strong research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s subsidiary that is wholly-owned Probulin Probiotics, is amongst the fastest-growing probiotics businesses in the us, according to SPINs reported information. HempFusion’s CBD items are considering a proprietary Food that is whole Hemp and they are available in-store or by going to HempFusion on the web at www.hempfusion.com or www.probulin.com.

Follow HempFusion on Twitter, Twitter and Instagram and Probulin on Twitter, Twitter and Instagram.


This news launch contains forward-looking statements and information that is forward-looking the meaning of Canadian securities legislation (collectively, “forward-looking statements“) that relate to HempFusion’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such statements that are forward-looking in this news launch really should not be unduly relied upon. These statements talk just at the time of the date of the news launch. This news release contains forward-looking statements relating to the Company’s continued sales within the UK, preparation for anticipated EU regulations, compliance with the requirements of the FSA, planned expansion throughout the UK and the EU and the Company’s other plans, focus and objectives in particular and without limitation.

Forward-looking statements are derived from lots of presumptions and they are susceptible to lots of dangers and uncertainties, a lot of that are beyond HempFusion’s control, which may cause real outcomes and activities to differ materially from those who are disclosed in or suggested by such statements that are forward-looking. Such risks and uncertainties include, but are not limited to, the impact and progression of the pandemic that is COVID-19 other factors set forth under “Forward-Looking Statements” and “Risk facets” within the last long type prospectus associated with business dated December 17, 2020 and available beneath the Company’s profile on SEDAR at www.sedar.com. HempFusion undertakes no responsibility to upgrade or revise any statements that are forward-looking whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for HempFusion to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any statement that is forward-looking. Any forward-looking statements found in this news launch are expressly qualified within their entirety by this statement that is cautionary.

Neither the TSX nor its Regulation Services Provider (as that term is defined within the policies for the TSX) takes obligation for the adequacy or precision of the launch.

Latest posts